| Literature DB >> 21365321 |
Lindsay J Edwards1, Brian D Evavold.
Abstract
T cell recognition of antigen is a crucial aspect of the adaptive immune response. One of the most common means of pathogen immune evasion is mutation of T cell epitopes. T cell recognition of such ligands can result in a variety of outcomes including activation, apoptosis and anergy. The ability of a given T cell to respond to a specific peptide-MHC ligand is regulated by a number of factors, including the affinity, on- and off-rates and half-life of the TCR-peptide-MHC interaction. Interaction of T cells with low-potency ligands results in unique signaling patterns and requires engagement with a larger number of T cell receptors than agonist ligands. This review will address these aspects of T cell interaction with weak ligands and the ways in which these ligands have been utilized therapeutically.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21365321 PMCID: PMC3107861 DOI: 10.1007/s12026-011-8204-3
Source DB: PubMed Journal: Immunol Res ISSN: 0257-277X Impact factor: 2.829